This facility offers high-throughput, next-generation sequencing on two illumina HiSeq2500 and MiSeq platforms. We have expertise in whole-genome, exome, epigenetic and microbiome sequencing, and we ...
Optimized Detection of Unknown MET Exon 14 Skipping Mutations in Routine Testing for Patients With Non–Small-Cell Lung Cancer PMD and clonal hematopoiesis are both common in patients with AML in first ...